Search Results - "Joly, Pascal"

Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept study.

Authors: Koliadenko, Vlada Joly, Pascal Lemaire, Flora et al.

Source: British Journal of Dermatology. Dec2025, Vol. 193 Issue 6, p1257-1260. 4p.

An Organic-Inorganic Hybrid Composite as a Coating Agent.

Authors: Kuroda, Akihiro Joly, Pascal Shibata, Naoki

Source: Journal of the American Oil Chemists' Society (JAOCS); June 2008, Vol. 85 Issue 6, p549-553, 5p

Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis.

Authors: Kieffer, Camille Hebert, Vivien Joly, Pascal et al.

Source: Dermatology & Therapy. Jul2026, p1-15. 15p.

Prevention of recurrent erythema multiforme with lenalidomide: a case series.

Authors: Ingen-Housz-Oro, Saskia Joly, Pascal Kini-Matondo, Willy et al.

Source: Clinical & Experimental Dermatology. Feb2024, Vol. 49 Issue 2, p166-168. 3p.

Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping Review.

Authors: Tedbirt, Billal Korte, Eva W. H. Hiel, Marjolein A. J. et al.

Source: Clinical Drug Investigation. Nov2025, Vol. 45 Issue 11, p825-836.

Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series.

Authors: Hébert, Vivien Joly, Pascal

Source: Clinical & Experimental Dermatology. Nov2023, Vol. 48 Issue 11, p1258-1259. 2p.

This result is not displayed to guests.
Login for full access.

Biophysical induction of cell release for minimally manipulative cell enrichment strategies.

Authors: Joly, Pascal Schaus, Thomas Sass, Andrea et al.

Source: PLoS ONE. 6/30/2017, Vol. 12 Issue 6, p1-15. 15p.

This result is not displayed to guests.
Login for full access.

Geometry-Driven Cell Organization Determines Tissue Growths in Scaffold Pores: Consequences for Fibronectin Organization.

Authors: Joly, Pascal Duda, Georg N. Schöne, Martin et al.

Source: PLoS ONE. Sep2013, Vol. 8 Issue 9, p1-11. 11p.

The need to prevent corticosteroid‐induced myopathy in patients with autoimmune bullous skin diseases.

Authors: Joly, Pascal¹ (AUTHOR) pascal.joly@chu‐rouen.fr

Source: Journal of the European Academy of Dermatology & Venereology. Feb2025, Vol. 39 Issue 2, p251-252. 2p.

Wavelet preconditioning of the Stokes problem in ψ–ω formulation.

Authors: Joly, Pascal Masson, Roland

Source: Numerical Algorithms. Oct2000, Vol. 24 Issue 4, p357-369. 13p.

Individual meta‐analysis of vital prognostic factors of patients with bullous pemphigoid.

Authors: Tedbirt, Billal Joly, Pascal Gillibert, André

Source: Journal of the European Academy of Dermatology & Venereology. Jul2023, Vol. 37 Issue 7, pe917-e919. 3p.

Complex conjugate gradient methods.

Authors: Joly, Pascal Meurant, Gérard

Source: Numerical Algorithms. 1993, Vol. 4 Issue 3, p379-406. 28p.

Pemphigus.

Authors: Schmidt, Enno Kasperkiewicz, Michael Joly, Pascal

Source: Lancet. Sep2019, Vol. 394 Issue 10201, p882-894. 13p.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Authors: Berkani, Nicolas Joly, Pascal Golinski, Marie-Laure et al.

Source: Scientific Reports. Dec2019, Vol. 9 Issue 1, p1-1. 1p.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Authors: Joly, Pascal Maho-Vaillant, Maud Prost-Squarcioni, Catherine et al.

Source: Lancet. 5/20/2017, Vol. 389 Issue 10083, p2031-2040. 10p.

Synthesis and chemical reactivity of semicarbazide-supported silicas

Authors: Blanchet, Carl Joly, Pascal Granier, Michel et al.

Source: Tetrahedron Letters: International Organ for the Rapid Publication of Preliminary Communications in Organic Chemistry. May2003, Vol. 44 Issue 22, p4191. 4p.

Subjects: Xerogels, Silica, Organic synthesis

307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT.

Authors: Murrell, Dedee F. Joly, Pascal Werth, Victoria P. et al.

Source: British Journal of Dermatology. 2023 Supplement, Vol. 188, pii4-ii5. 2p.

Incidence and Mortality of Bullous Pemphigoid in France.

Authors: Joly, Pascal Baricault, Sophie Sparsa, Agnès et al.

Source: Journal of Investigative Dermatology. Aug2012, Vol. 132 Issue 8, p1998-2004. 7p.